Liver Cancer

San Francisco, CA—Less proved to be the equivalent of more in a randomized comparison of empty versus chemotherapy-filled embolization beads for the treatment of patients with hepatocellular carcinoma (HCC), as shown in the results of a randomized study presented at the 2013 Gastro­intestinal Cancers Symposium.

Results 1 - 1 of 1
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology